Investec Bank plc has filed a formal dealing disclosure under Rule 8.5 of the UK Takeover Code relating to Advanced Medical Solutions Group Plc (AMS.L).
The disclosure, submitted on 10th June 2026, covers transactions undertaken by Investec as an exempt principal trader with recognised intermediary status acting in a client-serving capacity.
Investec Bank serves as Advisor and Joint Broker to Advanced Medical Solutions Group plc, establishing its connection to the offer under the terms of the Code.
The dealing in question took place on 9th June 2026 and involved ordinary shares in Advanced Medical Solutions Group Plc.
Investec sold a total of 5,000 ordinary shares in Advanced Medical Solutions Group, with both the highest and lowest price per unit recorded at 219.5 pence.
The uniform sale price across the transaction indicates the entire block of shares was disposed of at a single consistent price point during the trading session.
No cash-settled derivative transactions were reported as part of this disclosure, with all relevant fields in that section recorded as not applicable.
Similarly, no stock-settled derivative transactions, including options, were written, purchased, sold, or varied in connection with this filing.
Investec confirmed there are no indemnity arrangements, option agreements, or understandings that may constitute an inducement to deal or refrain from dealing with any party to the offer.
The bank also confirmed no agreements or understandings exist relating to voting rights or the future acquisition or disposal of relevant securities referenced by any derivative instrument.
The disclosure was filed in accordance with the requirement for public disclosures under Rule 8 of the Takeover Code to be submitted to a Regulatory Information Service.
The contact named in the filing is Abhishek Gawde, reachable by telephone at +91-9923757332, as listed in the official regulatory submission.
